Abstract:Cardiac arrhythmias occurring during the intraoperative period for cardiac surgery have been associated with excess morbidity and mortality. Several antiarrhythmics have been utilized for the management of intraoperative arrhythmias. These antiarrhythmic medications can cause undesirable adverse outcomes in the intensive care setting. The incidence and treatment of adult intraoperative arrhythmias have been studied. In addition, the prevalence, risk factors, and optimal treatment of pediatric postoperative arrhythmias have also been studied. However, the literature has not been published on intraoperative antiarrhythmia treatment during pediatric cardiac surgery. The purpose of this study was to determine the safety of intraoperative antiarrhythmic medications utilized in pediatric cardiac surgery patients. This was a retrospective review of all patients who received an intraoperative antiarrhythmic in the cardiovascular operating room at Texas Children's Hospital. Patients were included if they underwent cardiovascular surgery from November 2008 to July 2013 and were excluded if antiarrhythmics were given intraoperatively for other indications (i.e., esmolol for hypertension) or if patients were older than 18 years of age. Safety of antiarrhythmic treatment was determined by the absence or presence of adverse events. Control or recurrence of the arrhythmia was analyzed as a secondary measure to help determine antiarrhythmic efficacy. A total of 45 patients were identified (53.3 % male). Patients were a median of 0.52 years at the time of surgery. Primary surgery types were tetralogy of Fallot repair (n = 6; 13.3 %) and ventricular septal defect closure (n = 5, 11.1 %). Thirty-one patients (68.9 %) had documented adverse events after the administration of antiarrhythmics. Most of these adverse events occurred after the administration of amiodarone (n = 16; 51.6 %) followed by esmolol (n = 15; 48.4 %). Fifty-one percent of the arrhythmias resolved in the operating room (n = 23), and nearly half (n = 19) of all patients were discharged home on an antiarrhythmic medication. A high incidence of adverse events was associated with intraoperative administration of antiarrhythmic medications.

Diagnosis and Treatment of Arrhythmias in Children with Congenital Heart Disease after Surgery

Study Progress of Diagnosis and Management of Arrhythmias Associated with Congenital Heart Disease in Children

The Progress and Challenges of Surgical Treatment for Congenital Heart Disease

Diagnosis and treatment of ventricular tachycardia in Children

[Cardiac arrhythmias in adults with congenital heart disease]

Tachyarrhythmias in congenital heart disease

Surgical Treatment on Congenital Heart Disease with Severe Pulmonary Hypertension

Prevalence of and risk factors for early postoperative arrhythmia in children after cardiac surgery

Clinical Diagnosis,Treatment and Decision-making of Fetal Cardiac Arrhythmias

Surgical Treatment of Primary Cardiac Tumor Associated with Malignant Arrhythmias

Treatment of Atrial Tachyarrythmia after Cardiac Operation

Diagnosis and treatment of neonatal arrhythmia

Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts

Pharmacotherapy of cardiac arrhythmias--basic science for clinicians.

Etiology and Treatment of Right Heart Failure in Children

The Prevention and Treatment of Arrhythmia During the Transcatheter Closure of Ventricular Septal Defect

Diagnosis Of Arrhythmias With Non-Invasive Tools

Arrhythmia of Transcatheter Closure of Ventricular Septal Defect in 356 Children

Pharmacotherapy of Cardiac Arrhythmias—Basic Science for Clinicians

Diagnosis and Intervention of Fetal Congenital Heart Diseases and Arrhythmias

Evaluating the Safety of Intraoperative Antiarrhythmics in Pediatric Cardiac Surgery Patients